$1,943,622
Total Seed Grants
Supporting Innovative New Research
Developing antibody-drug conjugate that targets stomach tumors
Pradeep Chaluvally-Raghavan, PhD
Medical College of Wisconsin
$100,000 granted in 2025
Uncovering how gastric tumors evolve and become resistant to treatment
Ignacio Vázquez-García, PhD
Massachusetts General Hospital and Harvard Medical School
$100,000 granted in 2025
The Novel Functions of WEE1 I Human Gastric Adenocarcinoma
Zheng Chen, MD, PhD
University of Miami Miller School of Medicine
$100,000 granted in 2024
Dissecting Putative Therapeutic Biomarker Co-expression and Tumor Microenvironment Dynamics in Early-Onset Gastroesophageal Cancers
Raghav Sundar, MD, PhD
Yale School of Medicine
$100,000 granted in 2024
Targeting TGFβ signaling in gastric cancer: A biomarker-driven approach towards clinical translation
Kishore Guda, DVM, PhD
Case Western Reserve University School of Medicine
$100,000 granted in 2023
Targeting claudin 18.2-expressing gastric cancer using T cell antigen coupler (TAC)-T cells
Ryan Moy, MD, PhD
Columbia University Irving Medical Center
$100,000 granted in 2023
Identifying and targeting peritoneal-specific immunosuppresive networkls in gastric cancer from patient-derived samples
Alexandra-Chloé Villani, PhD
Massachusetts General Hospital
$100,000 granted in 2023
Pre-clinical project to evaluate the effects of SCD1 inhibition in GCK mouse stomachs and to determine whether the SCD1 inhibition can be a possible therapeutic intervention or treatment in patients with gastric dysplasia or early-stage cancer
Eunyoung Choi, PhD
Vanderbilt University Medical Center
$100,000 granted in 2022
The Oral Commensal Bacterium Fusobacterium Nucleatum as a Potential Driver of Gastric Cancer
Dr. Nina Salama, Ph.D.
Fred Hutchinson Cancer Research Center
$100,000 granted in 2021
Utilization of molecular evaluation of clinically-annotated patient samples and the application of single cell RNA-sequencing to strong in vitro model systems to understand the therapeutic potential of platinum chemotherapy and PARP inhibitors in HR-deficient gastric cancer
Nilay Sethi, MD, PhD
Dana-Farber/Harvard Cancer Center
$100,000 granted in 2022
Targeting Myeloid Cells to Enhance Immune Checkpoint Blockade in Gastric Cancer
Dr. Timothy C. Wang, M.D
Columbia University
$100,000 granted in 2021
Exploiting KMT2 as a Predictive Marker and Therapeutic Target in Advanced Gastric Cancer
Dr. Heinz-Josef Lenz
USC Norris Comprehensive Cancer Center
$75,000 Granted in 2020
New Targets and Therapies for Chromosomal Instability Underlying Gastric Cancer
Dr. Adam Bass
Dana-Farber Cancer Institute
$75,000 Granted in 2020
Interperitoneal Project to Develop New Therapies for Peritoneal Caricinomatosis
Dr. Jaffer Ajani
MD Anderson Cancer Center
$75,000 Granted in 2019
Study to Test Effectiveness of Combination Drug Therapy to Target Gastric Cancers with FGFR2 Defect and Prevent Drug Resistance
Dr. Hanlee Ji
Stanford Genome Technology Center
$30,104 Granted in 2019
Studying the Gastric Cancer Microenvironment Using Single Cell Genomics
Dr. Hanlee Ji
Stanford Genome Technology Center
$38,518 Granted in 2019
Use of Next-Generation DNA Sequencing Technology to Perform Whole-Genome Level Analysis on large Cohort of Individuals with Gastric Cancer
Dr. James Ford
Stanford University Medical School
$550,000 Total Grants 2010-2015